Glaxosmithkline (GSK)

 

GSK Share PerformanceMore

52 week high1,745.5 11/10/16
52 week low1,363.0 24/06/16
52 week change 62.0 (4.12%)
4 week volume183,175,249 28/03/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director Deals - GlaxoSmithKline PLC (GSK)

Emma Walmsley, Executive Director, has re-invested 5,666 shares in the company on the 18th April 2017 at a price of 1647.0...

Director/PDMR Shareholding

RNS Number: 0292D GlaxoSmithKline PLC 21 April 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Dr S Dexter b) Position/status PCA of Dr P J T Vallance (President, R&D) c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance ma...

Director/PDMR Shareholding

RNS Number: 0192D GlaxoSmithKline PLC 21 April 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Ms E Walmsley b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participant...

Investment trust bargain hunter: Dividend hero slips to 10% discount

Our latest tip has a FTSE 100-beating yield of 4.2% and a 43-year track record of dividend growth. Kyle Caldwell unveils th...

Broker Forecast - Jefferies International issues a broker note on GlaxoSmithKline PLC

Jefferies International today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price ta...

Director/PDMR Shareholding

RNS Number: 7867C GlaxoSmithKline PLC 19 April 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Ms E Walmsley b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participant...

Director/PDMR Shareholding

RNS Number: 7752C GlaxoSmithKline PLC 19 April 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mrs V A Whyte b) Position/status Company Secretary c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participant, auc...

Director/PDMR Shareholding

RNS Number: 7740C GlaxoSmithKline PLC 19 April 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mr D E Troy b) Position/status SVP & General Counsel c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participant, au...

Fundamental DataMore

P/E ratio83.271
EPS18.8
Dividend yield5.11 %

Latest discussion posts More

  • Advair - Q update

    Teva's launch of a generic, though not Advair equivalent(lower dose) weighing on sentiment. Advair still gets so much attention even though the patent loss has been ...
    23-Apr-2017
    EssentialInvestor
  • NEW ARTICLE: Buy oil giants and this high-yielding blue chip

    "We're past peak OPECTo fathom oil prices - and gauge energy firms' earnings and the North Sea's economic prospects - don't fuss over OPEC. Fathom America's shale industry ...
    5-Apr-2017
    II Editor
  • Mylan's generic version of GSK's Advair rejected by FDA

    good news https://seekingalpha.com/news/3254222-mylans-generic-version-gsks-advair-rejected-fda-shares-2-percent?app=1&uprof=51#email_link
    30-Mar-2017
    gronch

Users' HoldingsMore

Users who hold Glaxosmithkline also hold..
VODAFONE GRP.35%
BP34%
NATIONAL GRID32%
RDS 'B'31%
LLOYDS GRP.30%

Codes & Symbols

ISINGB0009252882
SymbolsGSK, LSE:GSK, GSK.L, GSK:LN, LON:GSK, XLON:GSK